Concepedia

Author

Olga Lyass

Hadassah Medical Center

Also Known As

O Lyass, O. Lyass, Olga Lyass

23

Publications

2.3K

Citations

14

H-Index

39

Concepts

All Affiliations

Hadassah Medical CenterMemorial Sloan Kettering Cancer CenterDana-Farber/Harvard Cancer CenterThe Netherlands Cancer InstituteStanford Medicine
OL

About

Olga Lyass is an author at Hadassah Medical Center specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

851

2

Health Sciences

2

2

278

3

Immunology

1

1

44

4

Neurology

1

1

45

5

Neuroscience

1

1

45

Olga Lyass

×

15

Publications

2.3K

Citations

14

H-Index

YearCitations

Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2

Tamar Safra, Franco M. Muggia, Susan Jeffers,

Annals of Oncology

2000

611

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

Olga Lyass, Beatrice Uziely, Rami Ben‐Yosef,

Cancer

2000

387

Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy

Michael J. Zeléfsky, D. Crean, G Mageras,

Radiotherapy and Oncology

1999

243

Skin Toxic Effects of Polyethylene Glycol–Coated Liposomal Doxorubicin

Michal Lotem, Ayala Hubert, Olga Lyass,

Archives of Dermatology

2000

217

Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes

Zvi Symon, Amos Peyser, Dinah Tzemach,

Cancer

1999

209

Cardiac Safety of Pegylated Liposomal Doxorubicin (Doxil®/Caelyx®) Demonstrated by Endomyocardial Biopsy in Patients with Advanced Malignancies

Alberto Gabizón, Olga Lyass, Gerald J. Berry,

Cancer Investigation

2004

122

Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma

Benjamin Nisman, Joel Lafair, Norman Heching,

Cancer

1998

111

Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer

Ayala Hubert, Olga Lyass, Dov Pode,

Anti-Cancer Drugs

2000

87

Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy.

Michael J. Zeléfsky, Olga Lyass, Z. Fuks,

Journal of Clinical Oncology

1998

78

Phase I study of doxil-cisplatin combination chemotherapy in patients with advanced malignancies.

Olga Lyass, Ayala Hubert, Alberto Gabizón

PubMed

2001

46

Page 1